Insights

Strategic assets sale The company recently sold assets to Maravai LifeSciences, indicating potential for cross-sell of enzymatic DNA synthesis IP or licensing opportunities via existing buyers or partners in the ecosystem.

Licensing potential Former partner programs and the FES technology approach suggest there is demand for onsite synthesis licensing, creating a path for sales outreach to biotech developers seeking scalable DNA synthesis capabilities.

Partners and alliances Past activity launching a Partnering Program and collaboration with industry players positions MAI as a candidate to engage via OEM or joint development opportunities with contract manufacturers and tool vendors.

Funding tailwinds Historical investment from notable firms and a recent financing round signal market validation and potential for strategic partnerships or co-development funding discussions with investment-backed teams.

Market fit signals Recognition such as the BioTech Breakthrough award and focus on industrial synthetic biology, precision medicine, and bio-based electronics highlight target sectors where sales could emphasize speed, cost efficiency, and sustainability of enzymatic DNA synthesis.

Similar companies to Molecular Assemblies, Inc.

Molecular Assemblies, Inc. Tech Stack

Molecular Assemblies, Inc. uses 8 technology products and services including iCIMS, SOLIDWORKS, Amazon Web Services, and more. Explore Molecular Assemblies, Inc.'s tech stack below.

Media & News

Molecular Assemblies, Inc.'s Email Address Formats

Molecular Assemblies, Inc. uses at least 3 email formats:
Molecular Assemblies, Inc. Email FormatsExamplePercentage
First@molecularassemblies.comJohn@molecularassemblies.com
54%
First.Last@molecularassemblies.comJohn.Doe@molecularassemblies.com
45%
FLast@molecularassemblies.comJDoe@molecularassemblies.com
1%

Frequently Asked Questions

What is Molecular Assemblies, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Molecular Assemblies, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Molecular Assemblies, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Molecular Assemblies, Inc.'s official website is molecularassemblies.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Molecular Assemblies, Inc. generate?

Minus sign iconPlus sign icon
As of August 2026, Molecular Assemblies, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Molecular Assemblies, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Molecular Assemblies, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Molecular Assemblies, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2026, Molecular Assemblies, Inc. has approximately 4 employees across 2 continents, including North America and Europe. Key team members include Chief Technology Officer: P. P., Chief Technology Officer: P. P. and Senior Staff Engineer: P. H. Explore Molecular Assemblies, Inc.'s employee directory with LeadIQ.

What industry does Molecular Assemblies, Inc. belong to?

Minus sign iconPlus sign icon
Molecular Assemblies, Inc. operates in the Biotechnology Research industry.

What technology does Molecular Assemblies, Inc. use?

Minus sign iconPlus sign icon
Molecular Assemblies, Inc.'s tech stack includes iCIMS, SOLIDWORKS, Amazon Web Services, WordPress, Shopify, Microsoft 365, Pardot and Piwik PRO Core.

What is Molecular Assemblies, Inc.'s email format?

Minus sign iconPlus sign icon
Molecular Assemblies, Inc.'s email format typically follows the pattern of First@molecularassemblies.com. Find more Molecular Assemblies, Inc. email formats with LeadIQ.

How much funding has Molecular Assemblies, Inc. raised to date?

Minus sign iconPlus sign icon
As of August 2026, Molecular Assemblies, Inc. has raised $91M in funding. The last funding round occurred on Aug 28, 2024 for $4M.

When was Molecular Assemblies, Inc. founded?

Minus sign iconPlus sign icon
Molecular Assemblies, Inc. was founded in 2013.
Molecular Assemblies, Inc. logo

Molecular Assemblies, Inc.

Biotechnology ResearchCalifornia, United States2-10 Employees

Molecular Assemblies, Inc. is a private biotechnology company based in San Diego that develops enzymatic DNA synthesis technology. Its Fully Enzymatic Synthesis approach aims to produce long, high-quality DNA with sequence specificity in a way that mirrors natural DNA production, emphasizing reliability, affordability, and sustainability.

The technology is intended to enable reading and writing DNA for diverse sectors, including industrial synthetic biology, precision medicine, and emerging fields such as nanomachines and bio-based electronics. The company serves the broader life sciences market and is positioned as a smaller player within the biotechnology research industry. In January 2025, reports indicate MAI sold intellectual property and assets to Maravai LifeSciences, and had reportedly terminated most employees and paused normal operations in the preceding months.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
2-10

Section iconFunding & Financials

  • $91M

    Molecular Assemblies, Inc. has raised a total of $91M of funding over 10 rounds. Their latest funding round was raised on Aug 28, 2024 in the amount of $4M as a Grant.

  • $1M - $10M

    Molecular Assemblies, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.